Edwards Lifesciences Corp.

Edwards Lifesciences Corp.

Edwards Lifesciences Corp.

Overview
Date Founded

1999

Headquarters

One Edwards Way Irvine CA 92614

Type of Company

Public

Employees (Worldwide)

13.9K

Industries

Medical Products & Equipment
Medical Support Services
Biotechnology
Hospitals & Patient Services

Company Description

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..

Contact Data
Trying to get in touch with decision makers at Edwards Lifesciences Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

Corporate Vice President & Chief Financial Officer

Corporate Vice President, General Counsel

Corporate Vice President, Advanced Technology Chief Scientific Officer

Principal Accounting Officer

Corporate Vice President, Japan, Asia & Pacific

Corporate Vice President, Transcatheter Aortic Valve Replacement

Vice President-Strategy & Corporate Development

Corporate Vice President, Quality, Regulatory, Clinical

Corporate Vice President, Public Affairs

Board of Directors

Chairman & Chief Executive Officer at Edwards Lifesciences Corp.

Co-Founder at Versant Venture Management LLC

Former Interim President & Chief Executive Officer at Intersect ENT, Inc.

Former Senior Vice President, Professional Services at University of Pennsylvania

Director at Teledyne Instruments, Inc.

Former Chief Operating Officer & Executive Vice President at Textron, Inc.

Managing Director & Director at SPR Therapeutics LLC

President at Ingram Micro Asia Holdings, Inc.

Vice President, Associate General Counsel & Secretary at Edwards Lifesciences Corp.

Paths to Edwards Lifesciences Corp.
Potential Connections via
Relationship Science
You
Edwards Lifesciences Corp.
Owners & Shareholders
Details Hidden

Jennison Associates has expertise in a range of equity strategies across styles and market-caps, as well as fixed income strategies. The firm manages portfolios based on internal fundamental research, bottom-up security selection and a highly interactive investment process. They offer select capabilities in the following investment disciplines: Growth Equity, Opportunistic Equity, Small and Mid Cap Equity, Global Equity, Value Equity, Income & Infrastructure Equity and Fixed Income. Additionally, we offer Custom Solutions, Combination Strategies and Sector Strategies. Jennison Associates specializes in fundamental analysis, which involves attempting to gain insight into the future value of a company by studying company-specific and market-related quantitative (such as financial statements) and qualitative (such as quality of company management or products) information. Although portfolio managers ultimately make investment decisions for the portfolios they manage, they work closely with research analysts and other portfolio managers in a dynamic and continuous process of updating and debating investment ideas and company-specific convictions.

Details Hidden

Walter Scott's investment research team is grouped into three geographical regions - EMEA (Europe, Middle-East and Africa), Americas, and Asia Pacific - with individuals periodically rotated across these teams in order to build global knowledge and investment expertise. Research is consciously bottom-up and all investment professionals are generalists, covering all sectors. Irrespective of mandate, every portfolio is managed by bringing together the skill, judgment and experience of both the Investment Research team and the Investment Executive. A fundamental, bottom-up investment approach combines detailed financial research with business and industry analysis. Each company is researched using the same pillars of analysis. Meetings with company management are central to the process. Walter Scott's research process begins with financial statements from the company's annual report and accounts which are analyzed and interpreted through a standardized framework. This is quantitative, thereafter, everything is a qualitative judgment about the investment candidate. Investment decisions rest upon original research conducted in-house.

Details Hidden

SCM employs fundamental, bottom-up, and company-focused research in their investment process. They maintain a single growth-oriented philosophy that is applied across all strategies. The Select Growth strategy provides clients with exposure to their best 25-30 growth opportunities through a concentrated portfolio of primarily large- and mid-capitalization growth businesses. Portfolio companies are primarily domiciled in the US but also include the equity securities of issuers in other developed and emerging markets. The firm's Global Growth strategy is a concentrated portfolio that typically includes 30-50 issuers that are domiciled in both developed and emerging markets. Their Global Leaders strategy is almost the same with the Global Growth strategy. Sands' Emerging Markets Growth strategy is a concentrated portfolio that typically includes 30-50 issuers that are domiciled in or have significant exposure to emerging and frontier markets. The firm's Technology Innovators strategy is a concentrated portfolio of growth businesses which may be publicly or privately held, with a particular emphasis placed on companies classified in the technology sector, typically including 20-35 issuers. Sands' Focus strategy is a concentrated portfolio of primarily large-capitalization growth businesses that typically includes 5-20 issuers. Portfolio companies are selected from Sands' other equity strategies.

Recent Transactions
Details Hidden

Edwards Lifesciences Corp. purchases CAS Medical Systems Inc.

Details Hidden

Edwards Lifesciences Corp. purchases Mitralign, Inc. from Oxford Bioscience Partners, Giza Venture Capital, Orchestra Medical Ventures LLC, Triathlon Medical Venture Partners LLC, Forbion Capital Partners Management Holding BV, Palisade Capital Management (Private Equity)

Details Hidden

Edwards Lifesciences Corp., Edwards Lifesciences AG purchase ICU Medical Inc /Dominican Republic Manufacturing Facility from ICU Medical, Inc.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Legal Advisor

Advised onEdwards Lifesciences Corp. purchases Percutaneous Valve Technologies, Inc.

Accountant

Advised onEdwards Lifesciences Corp. purchases Percutaneous Valve Technologies, Inc.

Legal Advisor

Advised onBaxter International, Inc. purchases Edwards Lifesciences Corp. /Renal Replacement Therapy Bus from Edwards Lifesciences Corp.

Legal Advisor

Advised onEdwards Lifesciences Corp. purchases Harpoon Medical, Inc. from The Maryland Venture, Epidarex Capital Partners LLC

Legal Advisor

Advised onEdwards Lifesciences Corp. purchases Harpoon Medical, Inc. from The Maryland Venture, Epidarex Capital Partners LLC

Associate

Advised onEdwards Lifesciences Corp. purchases Valtech Cardio Ltd. from NGN Capital LLC, GlenRock Israel Ltd., Peregrine Ventures Management Ltd., Incentive Incubator Ltd.

Advisors & Consultants
Legal Advisor

Chair, Executive Compensation & Employee Benefits Practice at O'Melveny & Myers LLP

Legal Advisor

Partner at O'Melveny & Myers LLP

Legal Advisor

Partner at Paul, Weiss, Rifkind, Wharton & Garrison LLP

Clients

Our Lady of Lourdes Medical Center provides general medical and surgical services. It provides cardiac services, dialysis, organ transplantation and rehabilitation center. The company was founded in 1950 and is headquartered in Camden, NJ.

Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. Its artificial heart is intended for patients with advanced cardiac insufficiency that is ineligible for a transplant and have exhausted all medication alternatives. The company also develops electrical power supply system and telediagnostics system. Carmat was founded by Pouletty Philippe and Alain Carpentier on June 25, 2008 and is headquartered in Vélizy Villacoublay, France.

Key Stats and Financials As of 2019
Market Capitalization
$48.1B
Total Enterprise Value
$48.7B
Earnings Per Share
$4.93
Revenue
$4.35B
Total Equity
$4.15B
Total Debt
$679M
Net Profit
$1.05B
Enterprise Value Sales
11.19x
TEVNet Income
46.49x
Debt TEV
0.01x
Three Year Compounded Annual Growth Rate Of Revenue
13.63%
Five Year Compounded Annual Growth Rate Of Revenue
13.36%
EBITDAMargin
30.19%
EBITDA
$1.31B
Enterprise Value EBITDAOperating
37.01x
Investments
Details Hidden

CardioFocus, Inc. develops and markets catheter-based approach to treating atrial fibrillation. Its CardioFocus endoscopic ablation system consist ballon catheter, deflectable sheath introducer, and endoscope. The firm serves clients in the United States. The company was founded by Edward Sinofsky in 1990 and is headquartered in Marlborough, MA.

Details Hidden

V-Wave Ltd. engages in the development of implantable medical device for treating chronic heart failure. It offers V-Wave Shunt, which is a biocompatible inter-atrial unidirectional implant. The company was founded by Gad Keren and Yaacov Nitzan in 2009 and is headquartered in Caesarea, Israel.

Details Hidden

CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA.

Suppliers
SurModics, Inc. Medical Products & Equipment | Eden Prairie, MN

SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

Symmetry Medical, Inc. Medical Products & Equipment | WARSAW, IN

Symmetry Medical, Inc. manufactures comprehensive surgical instruments for orthopedic and other medical device disciplines. It offers product development, project management, professional services, photochemical etching, contract implants, precision surgical instruments and sterilization case and trays. The company was founded in 1976 and is headquartered in Warsaw, IN.

TI Gotham, Inc. Internet Software & Services | New York, New York

Time, Inc. operates as a magazine publisher in the United States. Its brands include People, Sports Illustrated, InStyle, Time, Real Simple, Southern Living, Entertainment Weekly and Fortune. The company operates sites such as TIME.com, CNNMoney.com, PEOPLE.com and SI.com. Its products portfolio includes Style & Entertainment, Lifestyle, Luxury, News, Business, Sports and International. The company was founded by Henry Robinson Luce and Briton Hadden on November 28, 1922 and is headquartered in New York, NY.

Competitors
Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Medtronic Plc Medical Products & Equipment - Dublin, DU

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Boston Scientific Corporation Medical Products & Equipment - MARLBOROUGH, MA

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions. The Rhythm Management segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal, and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Awards & Honors
Rank #845
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Edwards Lifesciences Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Edwards Lifesciences Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Edwards Lifesciences Corp..